These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Myocardial repolarization and drugs. Impossibility to predict the dominance of anti-arrhythmic over pro-arrhythmic effects of drugs due to differential and ventricular electrical remodeling. Vos MA; Crijns HJ Anadolu Kardiyol Derg; 2001 Mar; 1(1):27-34. PubMed ID: 12122969 [TBL] [Abstract][Full Text] [Related]
32. Risk prediction for adverse events during initiation of sotalol and dofetilide for the treatment of atrial fibrillation. Agusala K; Oesterle A; Kulkarni C; Caprio T; Subacius H; Passman R Pacing Clin Electrophysiol; 2015 Apr; 38(4):490-8. PubMed ID: 25626340 [TBL] [Abstract][Full Text] [Related]
33. Pure class III antiarrhythmic drugs: focus on dofetilide. Doshi SK; Singh BN J Cardiovasc Pharmacol Ther; 2000 Oct; 5(4):237-47. PubMed ID: 11150393 [No Abstract] [Full Text] [Related]
34. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies. Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243 [TBL] [Abstract][Full Text] [Related]
36. Dofetilide: a new class III antiarrhythmic agent. Roukoz H; Saliba W Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):9-19. PubMed ID: 17187453 [TBL] [Abstract][Full Text] [Related]
37. [Sotalol in treatment of pediatric severe (refractory) cardiac arrhythmias]. Guo BJ; Li XM; Lu P; Qin DG; Wang L Zhonghua Er Ke Za Zhi; 2003 Oct; 41(10):780-1. PubMed ID: 14731366 [No Abstract] [Full Text] [Related]
38. Cumulative experience of azimilide-associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database. Pratt CM; Al-Khalidi HR; Brum JM; Holroyde MJ; Schwartz PJ; Marcello SR; Borggrefe M; Dorian P; Camm AJ; J Am Coll Cardiol; 2006 Aug; 48(3):471-7. PubMed ID: 16875971 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and proarrhythmia of oral sotalol in pediatric patients. Pfammatter JP; Paul T; Lehmann C; Kallfelz HC J Am Coll Cardiol; 1995 Oct; 26(4):1002-7. PubMed ID: 7560592 [TBL] [Abstract][Full Text] [Related]
40. Dofetilide: a class III-specific antiarrhythmic agent. Kalus JS; Mauro VF Ann Pharmacother; 2000 Jan; 34(1):44-56. PubMed ID: 10669186 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]